These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2557146)

  • 1. Positive inotropic effect of the thromboxane analog U-46619 on guinea pig left atrium: mediation by specific receptors and association with increased phosphoinositide turnover.
    Sakuma I; Gross SS; Levi R
    Can J Physiol Pharmacol; 1989 Aug; 67(8):943-9. PubMed ID: 2557146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive inotropic effect of histamine on guinea pig left atrium: H1-receptor-induced stimulation of phosphoinositide turnover.
    Sakuma I; Gross SS; Levi R
    J Pharmacol Exp Ther; 1988 Nov; 247(2):466-72. PubMed ID: 2846821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of histamine receptors modulating inotropic and biochemical activities in rabbit left atria.
    Hattori Y; Gando S; Endou M; Kanno M
    Eur J Pharmacol; 1991 Apr; 196(1):29-36. PubMed ID: 1651868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H1 - and H2-receptor mediated responses to histamine on contractility and cyclic AMP of atrial and papillary muscles from guinea-pig hearts.
    Reinhardt D; Schmidt U; Brodde OE; Schümann HJ
    Agents Actions; 1977 Mar; 7(1):1-12. PubMed ID: 193383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thromboxane agonists on cardiac adrenergic neurotransmission.
    Mantelli L; Amerini S; Rubino A; Ledda F
    Eur J Pharmacol; 1992 Mar; 213(1):79-85. PubMed ID: 1323473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A; Shirakura S; Higo K; Kubo K
    Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S; Whittle BJ
    Br J Pharmacol; 1986 Aug; 88(4):931-6. PubMed ID: 3017497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes alters the reactivity of myocardium to a thromboxane analogue.
    Canga L; Gorelik G; Sterin-Borda L
    Can J Physiol Pharmacol; 1987 Apr; 65(4):499-503. PubMed ID: 2886201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
    Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
    Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
    Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML; Allen GT
    J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EP 171: a high affinity thromboxane A2-mimetic, the actions of which are slowly reversed by receptor blockade.
    Jones RL; Wilson NH; Lawrence RA
    Br J Pharmacol; 1989 Apr; 96(4):875-87. PubMed ID: 2743082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action.
    Hattori Y; Levi R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):719-24. PubMed ID: 3012066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat.
    Ko FN; Yu SM; Kang YF; Teng CM
    Br J Pharmacol; 1995 Sep; 116(2):1801-8. PubMed ID: 8528563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does thromboxane mediate the indirect contractile action of leukotriene D4 in guinea-pig isolated lung parenchyma under equilibrium conditions?
    Giembycz MA; Rodger IW
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1467-77. PubMed ID: 3664360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.